Stockscreener 앱 받기
1.38
0.00%
0.00
시간 외 거래:
1.38
Stereotaxis Inc 주식(STXS)의 최신 뉴스
Stereotaxis, Inc. introduces MAGiC ablation tip for efficient energy delivery - Traders Union
Stereotaxis, Inc. SEC Filing (Aug 14, 2026) - Stock Titan
Stereotaxis (STXS) Stock Sees Little Reward For Recurring Revenue Progress - Sahm
Stereotaxis, Inc. completes Robocath deal as GenesisX gains first U.S. customer - Traders Union
Stereotaxis, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Stereotaxis Q2 Earnings Call Highlights - TradingView
Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Is Stereotaxis Inc (STXS) Undervalued Despite Q2 Revenue Miss? G - GuruFocus
Stereotaxis robotic catheter sales surge 270% in Q2 despite revenue miss - scanx.trade
Transcript : Stereotaxis, Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates - The Manila Times
Stereotaxis Q2 revenue misses estimates, dragged by system decline - TradingView
Stereotaxis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Stereotaxis’ First U.S. GenesisX Robot to Be Installed This Fall - Stock Titan
BRIEF-Stereotaxis Q2 Revenue USD 7.67 Million Vs. IBES Estimate USD 8.35 Million - TradingView
Stereotaxis Inc (STXS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Stereotaxis Inc (RJR1.DU) Analyst insights, Price targets and Recommendations - Yahoo Finance Australia
Enterprise value to revenue forward of Stereotaxis, Inc. – FWB:RJR1 - TradingView
Stereotaxis, Inc. brings GenesisX robot for community heart health education in St. Louis - Traders Union
Stereotaxis (STXS) Projected to Release Quarterly Earnings on Tuesday - marketbeat.com
Stereotaxis Inc (STXS) Institutional Confidence - tradingkey.com
Stereotaxis Inc (STXS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Stereotaxis Inc (STXS) Cash Flow - TradingKey
Stereotaxis Inc (STXS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Stereotaxis Inc (STXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Stereotaxis Inc (STXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Stereotaxis Inc (STXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
STXS|Stereotaxis Inc|Price:1.260|Chg%:-0.070 - TradingKey
STXS|Stereotaxis Inc|Price:1.300|Chg%:+0.010 - TradingKey
Stereotaxis Inc (STXS) Balance Sheet - TradingKey
Stereotaxis, Inc. Revenue Breakdown – AMEX:STXS - TradingView
Stereotaxis Inc. (STXS) Stock Price | Live Quotes & Charts | AMEX - timothysykes.com
Stereotaxis Inc (STXS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Stereotaxis, Inc. (STXS) stock price, news, quote and history - Yahoo Finance UK
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026 - The Manila Times
Stereotaxis to Discuss Robotic Intervention Results on Aug. 11 - Stock Titan
Stereotaxis, Inc. opens new robotic EP laboratory in Hungary - Traders Union
University of Szeged Pioneers First Robotic Cardiology Program in Hungary - GlobeNewswire
University of Szeged Treats First Patients With Genesis System - Stock Titan
Stereotaxis (STXS) Could Be 56% Undervalued After Shelf Registration Filings - Yahoo Finance
Stereotaxis, Inc.: University of Szeged Pioneers First Robotic Cardiology Program in Hungary - FinanzNachrichten.de
STXS Slides As Stereotaxis Clears Massive Secondary Share Block - timothysykes.com
Stereotaxis (NYSEAMERICAN:STXS) Shares Down 6.1%What's Next? - MarketBeat
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Stereotaxis Faces Integration, Financial, and Regulatory Challenges Following Robocath Acquisition - Minichart
Stereotaxis completes acquisition of Robocath; issues 6.27M shares, up to $25M earnout possible - TradingView
Stereotaxis (NYSE American: STXS) flags Robocath earnouts and 19.9% dilution - Stock Titan
Stereotaxis Files Resale Registration for Up to 108.9 Million Shares - Moomoo
Form S-3 Stereotaxis Inc For: 15 July By Investing.com - Investing.com Nigeria
Stereotaxis Finalizes Robocath Acquisition - dicardiology.com
ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now? - TradingView
Stereotaxis Inc. (STXS) Slides 2.3% as Shares Approach Critical Support at $1.61NAAIM Exposure - dars.gov.et
Stereotaxis closes Robocath takeover - MedTech Dive
Stereotaxis completes acquisition of Robocath By Investing.com - Investing.com India
Stereotaxis, Inc. completes Robocath acquisition to accelerate endovascular robotics expansion - Traders Union
Stereotaxis Closes $45M Deal for Robocath - Medical Product Outsourcing
Stereotaxis completes acquisition of Robocath - Investing.com
Robocath deal adds stock, warrants and earnouts at Stereotaxis (STXS) - Stock Titan
Stereotaxis Completes Acquisition of Robocath - GlobeNewswire
Enterprise value to revenue forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView
Price to sales forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView
Enterprise value to EBITDA forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView
Stereotaxis, Inc. completed the acquisition of Robocath SAS. - marketscreener.com
Enterprise value to EBITDA forward of Stereotaxis, Inc. – LS:A1J09L - TradingView
Price to book forward of Stereotaxis, Inc. – AMEX:STXS - TradingView
Director Ross B. Levin receives 43,103 Stereotaxis (STXS) restricted share units - Stock Titan
2.90%
1.18%
자본화:
|
볼륨(24시간):